Cited by 170Immune Cell Function and InteractionImmunotherapy and Immune Responsesinterferon and immune responses

The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.

A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity

Open access

Diefenbach, Andreas, Hsia, Jennifer K., Hsiung, Ming‐Yu B., Raulet, David H.·2003·European Journal of Immunology

DOI 10.1002/immu.200310012

Open this paper in CoChat — free account Open PDF

Abstract

NK cells are involved in the immune response against viral and microbial infections and tumors. In contrast to B and T cells, NK cells employ various modes of immune recognition. An important mode of immune recognition employed by NK cells is "induced self recognition" exemplified by the NKG2D receptor–ligand system. The NKG2D immunoreceptor, expressed by NK cells, and by activated CD8+ T cells and macrophages, recognizes one of several cell surface ligands that are distantly related to MHC class I molecules (i.e. H60 and Rae1 proteins in mice, and MHC class I chain‐related proteins and UL‐16‐binding proteins in humans). These ligands are not expressed abundantly by most normal cells but are up‐regulated on cells exposed to various forms of cellular insults.Here we report the cloning of another ligand for NKG2D; transcripts of this ligand are found in a wide variety of tissues and in various tumor cells. Cross‐linking of NKG2D with the novel ligand potently activated NK cells and macrophages. Tumor cells ectopically expressing the molecule were efficiently rejected by naive mice, and induced strong protective immunity to the parental, ligand‐negative tumor cells.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/immu.200310012

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J., Lanier, L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 3,272
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
In search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687
Production of high-titer helper-free retroviruses by transient transfection.
Pear, W. S., Nolan, G. P., Scott, M. L., & Baltimore, D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8392 · Cited by 2,267
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali‐Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J. E., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,918
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,773
ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.
Cosman, D., Müllberg, J., Sutherland, C. L., Chin, W. A., Armitage, R., Fanslow, W., Kubin, M., & Chalupny, N. (2001) · Immunity · doi:10.1016/s1074-7613(01)00095-4 · Cited by 1,394

Flagged first, then by citations

Show all 41 references

1 of the 41 references couldn’t be matched to a known paper.

Sorted by citations

The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,192
NK CELL RECOGNITION
Lanier, L. L. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,765
Roles of the NKG2D immunoreceptor and its ligands
Raulet, D. H. (2003) · Nature reviews. Immunology · doi:10.1038/nri1199 · Cited by 1,351
Self-citation
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H. (2005) · Nature · doi:10.1038/nature03884 · Cited by 1,308
Self-citation
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Abel, A. M., Yang, C., Thakar, M. S., & Malarkannan, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01869 · Cited by 1,150
Cancer Immunosurveillance and Immunoediting: The Roles of Immunity in Suppressing Tumor Development and Shaping Tumor Immunogenicity
Smyth, M. J., Dunn, G. P., & Schreiber, R. D. (2006) · Advances in immunology · doi:10.1016/s0065-2776(06)90001-7 · Cited by 919
Regulation of Ligands for the NKG2D Activating Receptor
Raulet, D. H., Gasser, S., Gowen, B. G., Deng, W., & Jung, H. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095951 · Cited by 877
Self-citation
The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
Paul, S., & Lal, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01124 · Cited by 896
NK cells and cancer immunosurveillance
Waldhauer, I., & Steinle, A. (2008) · Oncogene · doi:10.1038/onc.2008.267 · Cited by 682
Self-tolerance of natural killer cells
Raulet, D. H., & Vance, R. E. (2006) · Nature reviews. Immunology · doi:10.1038/nri1863 · Cited by 603
Self-citation
Activating and inhibitory receptors of natural killer cells
Pegram, H. J., Andrews, D. M., Smyth, M. J., Darcy, P. K., & Kershaw, M. H. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2010.78 · Cited by 583
Regulation of immune cell function and differentiation by the NKG2D receptor
Zafirova, B., Wensveen, F. M., Gulin, M., & Polić, B. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0797-0 · Cited by 562
Effect of NKG2D ligand expression on host immune responses
Champsaur, M., & Lanier, L. L. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00893.x · Cited by 509
Natural Killer Cells and Cancer
Wu, J., & Lanier, L. L. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)90004-2 · Cited by 435
p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells
Iannello, A., Thompson, T. W., Ardolino, M., Lowe, S. W., & Raulet, D. H. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130783 · Cited by 414
Self-citation
Interplay of natural killer cells and their receptors with the adaptive immune response
Raulet, D. H. (2004) · Nature Immunology · doi:10.1038/ni1114 · Cited by 413
Self-citation
NKG2D ligands in tumor immunity
Nausch, N., & Cerwenka, A. (2008) · Oncogene · doi:10.1038/onc.2008.272 · Cited by 422
Oncogenic stress sensed by the immune system: role of natural killer cell receptors
Raulet, D. H., & Guerra, N. (2009) · Nature reviews. Immunology · doi:10.1038/nri2604 · Cited by 405
Self-citation
NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects
Olson, J. A., Leveson-Gower, D. B., Gill, S. I., Baker, J. B., Beilhack, A., & Negrin, R. S. (2010) · Blood · doi:10.1182/blood-2009-05-222190 · Cited by 387
Promiscuity and the single receptor: NKG2D
Eagle, R. A., & Trowsdale, J. (2007) · Nature Reviews Immunology · doi:10.1038/nri2144 · Cited by 374
Reprogramming of CTLs into natural killer–like cells in celiac disease
Meresse, B., Curran, S. A., Ciszewski, C., Orbelyan, G., Setty, M., Bhagat, G., Lee, L., Tretiakova, M., Semrad, C., Kistner, E., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060028 · Cited by 322
Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction
Cao, W., Bover, L. C., Cho, M., Wen, X., Hanabuchi, S., Bao, M., Rosen, D. B., Wang, Y., Shaw, J. L., Du, Q., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090547 · Cited by 342
Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity
Andoniou, C. E., van Dommelen, S. L. H., Voigt, V., Andrews, D. M., Brizard, G., Asselin‐Paturel, C., Delale, T., Stacey, K. J., Trinchieri, G., & Degli‐Esposti, M. A. (2005) · Nature Immunology · doi:10.1038/ni1244 · Cited by 283
Viral modulation of NK cell immunity
Lodoen, M. B., & Lanier, L. L. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1066 · Cited by 234
Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand–expressing tumor cells
Coudert, J. D., Zimmer, J., Tomasello, E., Cebecauer, M., Colonna, M., Vivier, É., & Held, W. (2005) · Blood · doi:10.1182/blood-2005-03-0918 · Cited by 226
Cutting Edge: Toll-Like Receptor Signaling in Macrophages Induces Ligands for the NKG2D Receptor
Hamerman, J. A., Ogasawara, K., & Lanier, L. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2001 · Cited by 205
Cytomegalovirus Immune Evasion
Powers, C., DeFilippis, V. R., Malouli, D., & Früh, K. (2008) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-77349-8_19 · Cited by 187
Cancer and Innate Immune System Interactions
Liu, Y., & Zeng, G. (2012) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182518e83 · Cited by 189
Effects of Human Cytomegalovirus Infection on Ligands for the Activating NKG2D Receptor of NK Cells: Up-Regulation of UL16-Binding Protein (ULBP)1 and ULBP2 Is Counteracted by the Viral UL16 Protein
Rölle, A., Mousavi‐Jazi, M., Eriksson, M., Odeberg, J., Söderberg‐Nauclér, C., Cosman, D. J., Kärre, K., & Cerboni, C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.902 · Cited by 185
RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
Lam, A. R., Bert, N. L., Ho, S. S. W., Shen, Y. J., Tang, M. L. F., Xiong, G. M., Croxford, J. L., Koo, C. X., Ishii, K. J., Akira, S., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1703 · Cited by 179
Self-citation
The DNA Damage Response Arouses the Immune System
Gasser, S., & Raulet, D. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4603 · Cited by 182
Self-citation
NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of Cancer
Smyth, M. J., Swann, J. B., Kelly, J. M., Cretney, E., Yokoyama, W. M., Diefenbach, A., Sayers, T. J., & Hayakawa, Y. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041522 · Cited by 169
Self-citation
Identification and Characterization of a Novel Human Myeloid Inhibitory C-type Lectin-like Receptor (MICL) That Is Predominantly Expressed on Granulocytes and Monocytes
Marshall, A. S. J., Willment, J. A., Lin, H., Williams, D. L., Gordon, S., & Brown, G. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313127200 · Cited by 164
Regulation of ligands for the activating receptor NKG2D
Mistry, A. R., & O’Callaghan, C. A. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02652.x · Cited by 170
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors
André, P., Castriconi, R., Espéli, M., Anfossi, N., Juarez, T., Hüe, S., Conway, H., Romagné, F., Dondero, A., Nanni, M., et al. (2004) · European Journal of Immunology · doi:10.1002/eji.200324705 · Cited by 157
Self-citation
NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145
Krmpotić, A., Hasan, M., Loewendorf, A. I., Saulig, T., Halenius, A., Lenac, T., Polić, B., Bubić, I., Kriegeskorte, A. K., Pernjak-Pugel, E., et al. (2004) · Journal of Experimental Medicine · doi:10.1084/jem.20041617 · Cited by 182
The role of the NKG2D receptor for tumor immunity
Coudert, J. D., & Held, W. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.008 · Cited by 140
Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasis
Lo, H. C., Xu, Z., Kim, I. S., Pingel, B. C., Aguirre, S., Kodali, S., Liu, J., Zhang, W., Muscarella, A. M., Hein, S., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0068-9 · Cited by 136
Thy1+ Nk Cells from Vaccinia Virus-Primed Mice Confer Protection against Vaccinia Virus Challenge in the Absence of Adaptive Lymphocytes
Gillard, G. O., Bivas‐Benita, M., Hovav, A., Grandpre, L. E., Panas, M. W., Seaman, M. S., Haynes, B. F., & Letvin, N. L. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002141 · Cited by 130
IL-21 Enhances Tumor Rejection through a NKG2D-Dependent Mechanism
Takaki, R., Hayakawa, Y., Nelson, A., Sivakumar, P. V., Hughes, S. D., Smyth, M. J., & Lanier, L. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2167 · Cited by 126
Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn
Bloch‐Queyrat, C., Fondanèche, M., Chen, R., Yin, L., Relouzat, F., Veillette, A., Fischer, A., & Latour, S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050449 · Cited by 124
Stress Management
Gleimer, M., & Parham, P. (2003) · Immunity · doi:10.1016/s1074-7613(03)00272-3 · Cited by 121
Genetics, genomics, and evolutionary biology of NKG 2D ligands
Carapito, R., & Bahram, S. (2015) · Immunological Reviews · doi:10.1111/imr.12328 · Cited by 125
JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity
Li, C., Ge, B., Nicotra, M. L., Stern, J. N. H., Kopcow, H. D., Chen, X., & Strominger, J. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712310105 · Cited by 114
Immunosurveillance and immunotherapy of tumors by innate immune cells
Iannello, A., Thompson, T. W., Ardolino, M., Marcus, A., & Raulet, D. H. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.11.001 · Cited by 105
Self-citation
Costimulation of Dendritic Epidermal γδ T Cells by a New NKG2D Ligand Expressed Specifically in the Skin
Whang, M. I., Guerra, N., & Raulet, D. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802439 · Cited by 100
Self-citation
Signaling and ligand interaction of ILT7: receptor‐mediated regulatory mechanisms for plasmacytoid dendritic cells
Cao, W., & Bover, L. C. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00867.x · Cited by 107
Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress
Nice, T. J., Coscoy, L., & Raulet, D. H. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20081335 · Cited by 97
Self-citation
Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy
Zalfa, C., & Paust, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.633205 · Cited by 100
Delineation of antigen-specific and antigen-nonspecific CD8+ memory T-cell responses after cytokine-based cancer immunotherapy
Tietze, J. K., Wilkins, D. E. C., Sckisel, G. D., Bouchlaka, M. N., Alderson, K. L., Weiss, J. M., Ames, E., Bruhn, K. W., Craft, N. A., Wiltrout, R. H., et al. (2012) · Blood · doi:10.1182/blood-2011-07-369736 · Cited by 94
NKG2D-mediated activation of cytotoxic lymphocytes: Unique signaling pathways and distinct functional outcomes
Upshaw, J. L., & Leibson, P. J. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.03.001 · Cited by 94
Two Novel NKG2D Ligands of the Mouse H60 Family with Differential Expression Patterns and Binding Affinities to NKG2D1
Takada, A., Yoshida, S., Kajikawa, M., Miyatake, Y., Tomaru, U., Sakai, M., Chiba, H., Maenaka, K., Kohda, D., Fugo, K., et al. (2008) · Journal of Immunology · doi:10.4049/jimmunol.180.3.1678 · Cited by 99
The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease
Stojanovic, A., Correia, M. P., & Cerwenka, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00827 · Cited by 92
NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications
Siemaszko, J., Marzec-Przyszlak, A., & Bogunia‐Kubik, K. (2021) · Cells · doi:10.3390/cells10061420 · Cited by 92
Human Natural Killer Receptors, Co‐Receptors, and Their Ligands
Biassoni, R. (2009) · Current Protocols in Immunology · doi:10.1002/0471142735.im1410s84 · Cited by 84
A Dual Role for Talin in NK Cell Cytotoxicity: Activation of LFA-1-Mediated Cell Adhesion and Polarization of NK Cells
Mace, E. M., Monkley, S. J., Critchley, D. R., & Takei, F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.2.948 · Cited by 75
Innate Immune Recognition and Suppression of Tumors
Hayakawa, Y., & Smyth, M. J. (2006) · Advances in cancer research · doi:10.1016/s0065-230x(06)95008-8 · Cited by 71
Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3–CD16+ NK cells
Konjević, G. M., Martinović, K. M., Jurišić, V., Babović, N. L., & Spužić, I. (2009) · Biomarkers · doi:10.1080/13547500902814658 · Cited by 69
NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses
Zloza, A., Kohlhapp, F. J., Lyons, G. E., Schenkel, J. M., Moore, T. V., Lacek, A. T., O’Sullivan, J. A., Varanasi, V., Williams, J. W., Jagoda, M. C., et al. (2012) · Nature Medicine · doi:10.1038/nm.2683 · Cited by 67
Transcriptional regulation of MICA and MICB: A novel polymorphism in MICB promoter alters transcriptional regulation by Sp1
Rodríguez‐Rodero, S., Gonzalez, S. R., Rodrigo, L., Fernández-Morera, J. L., Martı́nez-Borra, J., López‐Vázquez, A., & López‐Larrea, C. (2007) · European Journal of Immunology · doi:10.1002/eji.200737031 · Cited by 65
Ras Activation Induces Expression of Raet1 Family NK Receptor Ligands
Liu, X. V., Ho, S. S. W., Tan, J. J., Kamran, N., & Gasser, S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200965 · Cited by 62
Recognition of infected cells by natural killer cells
Carayannopoulos, L. N., & Yokoyama, W. M. (2003) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.11.003 · Cited by 60
NKG2D receptor–mediated NK cell function is regulated by inhibitory Ly49 receptors
Regunathan, J., Chen, Y., Wang, D., & Malarkannan, S. (2004) · Blood · doi:10.1182/blood-2004-03-1075 · Cited by 58
NK Cell Receptors as Tools in Cancer Immunotherapy
Sentman, C. L., Barber, M. A., Barber, A. E., & Zhang, T. (2006) · Advances in cancer research · doi:10.1016/s0065-230x(06)95007-6 · Cited by 56
Obstructing Shedding of the Immunostimulatory MHC Class I Chain–Related Gene B Prevents Tumor Formation
Wu, J. D., Atteridge, C. L., Wang, X., Seya, T., & Plymate, S. R. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1305 · Cited by 55
Transcription analysis on response of porcine alveolar macrophages to Haemophilus parasuis
Wang, Y., Liu, C., Fang, Y., Liu, X., Li, W., Liu, S., Liu, Y., Liu, Y., Charreyre, C., Audonnet, J.-C., et al. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-68 · Cited by 53
The Natural Selection of Herpesviruses and Virus-Specific NK Cell Receptors
Sun, J. C.-Y., & Lanier, L. L. (2009) · Viruses · doi:10.3390/v1030362 · Cited by 52
Immunology of naturally transmissible tumours
Siddle, H. V. T., & Kaufman, J. (2014) · Immunology · doi:10.1111/imm.12377 · Cited by 49
Involvement of an NKG2D Ligand H60c in Epidermal Dendritic T Cell-Mediated Wound Repair
Yoshida, S., Mohamed, R. H., Kajikawa, M., Koizumi, J., Minami, T., Fugo, K., Otsuka, N., Maenaka, K., Yagita∥, H., Chiba, H., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102886 · Cited by 49
RAE1ε Ligand Expressed on Pancreatic Islets Recruits NKG2D Receptor-Expressing Cytotoxic T Cells Independent of T Cell Receptor Recognition
Markiewicz, M. A., Wise, E. L., Buchwald, Z. S., Pinto, A. K., Zafirova, B., Polić, B., & Shaw, A. S. (2012) · Immunity · doi:10.1016/j.immuni.2011.11.014 · Cited by 42
Cooperative action of CD8 T lymphocytes and natural killer cells controls tumour growth under conditions of restricted T‐cell receptor diversity
Shanker, A., Buferne, M., & Schmitt‐Verhulst, A. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03150.x · Cited by 42
Murine NKG2D ligands: “Double, double toil and trouble”
Samarakoon, A., Chu, H., & Malarkannan, S. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.09.035 · Cited by 41
Manipulation of NKG2D ligands by cytomegaloviruses: impact on innate and adaptive immune response
Jonjić, S. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00085 · Cited by 45
Activation of Natural Killer Cells: Underlying Molecular Mechanisms Revealed
Backström, E., Kristensson, K., & Ljunggren, H. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01475.x · Cited by 41
NKG2D-Dependent Activation of Dendritic Epidermal T Cells in Contact Hypersensitivity
Nielsen, M. M., Dyring‐Andersen, B., Schmidt, J. D., Witherden, D. A., Lovato, P., Woetmann, A., Ødum, N., Poulsen, S. S., Havran, W. L., Geisler, C., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.23 · Cited by 40
IFN‐γ Production and Degranulation are Differentially Regulated in Response to Stimulation in Murine Natural Killer Cells
Vahlne, G., Becker, S., Brodin, P., & Johansson, M. H. (2007) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2007.02026.x · Cited by 39
Distribution of Several Activating and Inhibitory Receptors on CD3−CD16+ NK Cells and Their Correlation with NK Cell Function in Healthy Individuals
Konjević, G. M., Martinović, K. M., Vuletić, A. M., Jurišić, V., & Spužić, I. (2009) · The Journal of Membrane Biology · doi:10.1007/s00232-009-9191-3 · Cited by 35
Brief Focal Cerebral Ischemia That Simulates Transient Ischemic Attacks in Humans Regulates Gene Expression in Rat Peripheral Blood
Zhan, X., Ander, B. P., Jickling, G. C., Turner, R. J., Stamova, B. S., Xu, H., Liu, D., Davis, R. R., & Sharp, F. R. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.189 · Cited by 35
Immunogenetics of the NKG2D ligand gene family
Kasahara, M., & Yoshida, S. (2012) · Immunogenetics · doi:10.1007/s00251-012-0638-9 · Cited by 37
Structural Analysis and Epitope Prediction of MHC Class-1-Chain Related Protein-A for Cancer Vaccine Development
Adekiya, T. A., Aruleba, R. T., Khanyile, S., Masamba, P., Oyinloye, B. E., & Kappo, A. P. (2017) · Vaccines · doi:10.3390/vaccines6010001 · Cited by 34
RAE‐1 is expressed in the adult subventricular zone and controls cell proliferation of neurospheres
Popa, N., Cédile, O., Pollet‐Villard, X., Bagnis, C., Durbec, P. L., & Boucraut, J. (2010) · Glia · doi:10.1002/glia.21074 · Cited by 33
Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer
Arina, A., Murillo, O., Dubrot, J., Azpilikueta, A., Alfaro, C., Perez‐Gracia, J. L., Bendandi, M., Palencia, B., Hervás‐Stubbs, S., & Melero, I. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.5.599 · Cited by 32
Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing–remitting multiple sclerosis
Fernández-Morera, J. L., Rodríguez‐Rodero, S., Lahoz, C., Tuñon, A., Astudillo, A., García‐Suárez, O., Martı́nez-Borra, J., López‐Vázquez, A., Rodrigo, L., Gonzalez, S. R., et al. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.01.021 · Cited by 32
pH-Triggered Copper-Free Click Reaction-Mediated Micelle Aggregation for Enhanced Tumor Retention and Elevated Immuno–Chemotherapy against Melanoma
Deng, M., Guo, R., Zang, S., Rao, J., Li, M., Tang, X., Xia, C., Li, M., Zhang, Z., & He, Q. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c02567 · Cited by 31
Human Natural Killer Receptors, Co‐Receptors, and Their Ligands
Biassoni, R., & Malnati, M. (2018) · Current Protocols in Immunology · doi:10.1002/cpim.47 · Cited by 31
The balancing act: Inhibitory Ly49 regulate NKG2D-mediated NK cell functions
Malarkannan, S. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.04.002 · Cited by 29
Imbalance of NKG2D and its inhibitory counterparts: How does tumor escape from innate immunity?
Zhang, C., Zhang, J., Wei, H., & Tian, Z. (2005) · International Immunopharmacology · doi:10.1016/j.intimp.2005.03.003 · Cited by 28
Combination therapy of DKK1 inhibition and NKG2D chimeric antigen receptor T cells for the treatment of gastric cancer
Zhang, Y.-P., Liang, K.-J., Zhou, X., Zhang, X., Xu, H., Dai, H., Song, X., Yang, X., Liu, B.-R., Shi, T., et al. (2023) · Cancer Science · doi:10.1111/cas.15828 · Cited by 24
Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction
Konjević, G. M., Martinović, K. M., Vuletić, A. M., & Radenković, S. (2010) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2010.06.013 · Cited by 27
Correction: Thy1+Nk Cells from Vaccinia Virus-Primed Mice Confer Protection against Vaccinia Virus Challenge in the Absence of Adaptive Lymphocytes
Gillard, G. O., Bivas‐Benita, M., Hovav, A., Grandpre, L. E., Panas, M. W., Seaman, M. S., Haynes, B. F., & Letvin, N. L. (2011) · PLoS Pathogens · doi:10.1371/annotation/b29086ef-e08d-444c-8113-18a6dd429a7c · Cited by 26
HOXB4-Transduced Embryonic Stem Cell-Derived Lin−c- kit + and Lin−Sca-1+ Hematopoietic Progenitors Express H60 and Are Targeted by NK Cells
Tabayoyong, W., Salas, J. G., Bonde, S., & Zavazava, N. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901807 · Cited by 25
Cancer immunotherapy and heat-shock proteins: promises and challenges
Manjili, M. H., Wang, X., MacDonald, I. J., Arnouk, H., Yang, G., Pritchard, M. T., & Subjeck, J. R. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.3.363 · Cited by 25
New twist on the regulation of NKG2D ligand expression
Cerwenka, A. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090225 · Cited by 26
NKG2D–NKG2D Ligand Interaction Inhibits the Outgrowth of Naturally Arising Low-Grade B Cell Lymphoma In Vivo
Raju, S., Kretzmer, L. Z., Koues, O. I., Payton, J. E., Oltz, E. M., Cashen, A. F., Polić, B., Schreiber, R. D., Shaw, A. S., & Markiewicz, M. A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501982 · Cited by 24
RB mutation and RAS overexpression induce resistance to NK cell-mediated cytotoxicity in glioma cells
Orozco‐Morales, M., Sánchez‐García, F. J., Cancela, I. G., Hernández‐Pedro, N., Costoya, J. A., de la Cruz, V. P., Moreno‐Jiménez, S., Sotelo, J., & Pineda, B. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0209-x · Cited by 23
Comparative genomic analysis of mammalian NKG2D ligand family genes provides insights into their origin and evolution
Kondo, M., Maruoka, T., Otsuka, N., Kasamatsu, J., Fugo, K., Hanzawa, N., & Kasahara, M. (2010) · Immunogenetics · doi:10.1007/s00251-010-0438-z · Cited by 26
NK Cells Use NKG2D to Recognize a Mouse Renal Cancer (Renca), yet Require Intercellular Adhesion Molecule-1 Expression on the Tumor Cells for Optimal Perforin-Dependent Effector Function
Abdool, K., Cretney, E., Brooks, A. D., Kelly, J. M., Swann, J. B., Shanker, A., Bere, E. W., Yokoyama, W. M., Ortaldo, J. R., Smyth, M. J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2575 · Cited by 23
Physiological roles of murine DAP10 adapter protein in tumor immunity and autoimmunity
Hyka‐Nouspikel, N., & Phillips, J. H. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00456.x · Cited by 22
Comparative genomics of the NKG 2D ligand gene family
Kasahara, M., & Sutoh, Y. (2015) · Immunological Reviews · doi:10.1111/imr.12320 · Cited by 18
Modular Activating Receptors in Innate and Adaptive Immunity
Berry, R., & Call, M. E. (2017) · Biochemistry · doi:10.1021/acs.biochem.6b01291 · Cited by 17

Authors: Diefenbach, A., Hsia, J. K., Hsiung, M. B., & Raulet, D. H.
Affiliations: University of California, Berkeley (US)
Corresponding author: Raulet, David H.
ORCID: Diefenbach, Andreas
Raulet, David H.
Venue: European Journal of Immunology
Publisher: Wiley
Published: 2003-01-27
Volume: 33
Issue: 2
Pages: 381-391
ISSN: 0014-2980 (ISSN-L)
1521-4141
DOI: 10.1002/immu.200310012
OpenAlex: W2090487140
Cited by: 170
References: 41
Citations by year: 2026: 3 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 2 · 2018: 5 · 2017: 5 · 2016: 3 · 2015: 8 · 2014: 5 · 2013: 5 · 2012: 10
FWCI: 4.65
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: European Journal of Immunology (publishedVersion)
PubMed (publishedVersion)
Funders: Howard Hughes Medical Institute
National Institutes of Health
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Keywords: NKG2D, NKG2D ligands, natural killer cells, macrophages, antitumor immunity, Rae1, tumor rejection, NK cell activation
MeSH terms: Amino Acid Sequence, Animals, Carrier Proteins, Cloning, Molecular, Cytotoxicity, Immunologic, Interferons, Killer Cells, Natural, Ligands, Macrophages, Membrane Proteins, Molecular Sequence Data, Neoplasm Transplantation, Neoplasms, Organ Specificity, Receptors, Immunologic, Recombinant Fusion Proteins, RNA, Messenger, Transfection, Transplantation, Isogeneic, Tumor Cells, Cultured, Histocompatibility Antigens Class I, Minor Histocompatibility Antigens, Lymphoma, T-Cell, Sequence Alignment, Genes, RAG-1, Sequence Homology, Amino Acid, Protein Structure, Tertiary, Mice, Knockout, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks